Works matching DE "ANTINEOPLASTIC combined chemotherapy protocols"
Results: 365
Pancreatic cancer: why we must be optimistic?
- Published in:
- Cancer & Metastasis Reviews, 2021, v. 40, n. 3, p. 659, doi. 10.1007/s10555-021-09994-y
- By:
- Publication type:
- Article
Unraveling a Psychiatric Puzzle: Corticosteroid-Induced Psychosis in Addison's Disease. A case report.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
The 10th Anniversary of Toxics : Recent Advances in Toxicology Research.
- Published in:
- Toxics, 2024, v. 12, n. 8, p. 538, doi. 10.3390/toxics12080538
- By:
- Publication type:
- Article
对比分析 FLOT 方案与 FOLFOX 方案治疗中晚期胃癌的近远期疗效 及对血清肿瘤标志物和 NRP-2 的影响.
- Published in:
- Progress in Modern Biomedicine, 2024, v. 24, n. 16, p. 3108, doi. 10.13241/j.cnki.pmb.2024.16.021
- By:
- Publication type:
- Article
Immuno-oncology and interventional oncology: a winning combination. The latest scientific evidence.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2019, v. 23, n. 12, p. 5343
- By:
- Publication type:
- Article
MMFSyn: A Multimodal Deep Learning Model for Predicting Anticancer Synergistic Drug Combination Effect.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 8, p. 1039, doi. 10.3390/biom14081039
- By:
- Publication type:
- Article
Combination of Antimalarial and CNS Drugs with Antineoplastic Agents in MCF-7 Breast and HT-29 Colon Cancer Cells: Biosafety Evaluation and Mechanism of Action.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 10, p. N.PAG, doi. 10.3390/biom12101490
- By:
- Publication type:
- Article
Clinical efficacy and tumour microenvironment influence of decitabine plus R-CHOP in patients with newly diagnosed diffuse large B-Cell lymphoma: Phase 1/2 and biomarker study.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 12, p. 1, doi. 10.1002/ctm2.584
- By:
- Publication type:
- Article
Prevotella contributes to individual response of FOLFOX in colon cancer.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 9, p. 1, doi. 10.1002/ctm2.512
- By:
- Publication type:
- Article
FOLFIRI-bevacizumab as a second-line treatment for advanced biliary tract cancer after gemcitabinebased chemotherapy.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1293670
- By:
- Publication type:
- Article
Systemic treatment of patients with locally advanced or metastatic cholangiocarcinoma - an Austrian expert consensus statement.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1225154
- By:
- Publication type:
- Article
Metabolic bulk volume predicts survival in a homogeneous cohort of stage II/III diffuse large B-cell lymphoma patients undergoing R-CHOP treatment.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1186311
- By:
- Publication type:
- Article
The clinical relevance and prediction efficacy from therapy of tumor microenvironment related signature score in colorectal cancer.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1123455
- By:
- Publication type:
- Article
Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1120967
- By:
- Publication type:
- Article
End-of-neoadjuvant treatment circulating microRNAs and HER2- positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2022.1028825
- By:
- Publication type:
- Article
Li-Doped Bioactive Ceramics: Promising Biomaterials for Tissue Engineering and Regenerative Medicine.
- Published in:
- Journal of Functional Biomaterials, 2022, v. 13, n. 4, p. 162, doi. 10.3390/jfb13040162
- By:
- Publication type:
- Article
Multicenter, single‐arm, phase II study of the continuous use of panitumumab in combination with FOLFIRI after FOLFOX for RAS wild‐type metastatic colorectal cancer: Exploratory sequential examination of acquired mutations in circulating cell‐free DNA
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2172, doi. 10.1002/ijc.34184
- By:
- Publication type:
- Article
Multiple ligands simultaneous molecular docking and dynamics approach to study the synergetic inhibitory of curcumin analogs on ErbB4 tyrosine phosphorylation.
- Published in:
- Research in Pharmaceutical Sciences, 2024, v. 19, n. 6, p. 754, doi. 10.4103/RPS.RPS_191_23
- By:
- Publication type:
- Article
Multiple ligands simultaneous molecular docking and dynamics approach to study the synergetic inhibitory of curcumin analogs on ErbB4 tyrosine phosphorylation.
- Published in:
- Research in Pharmaceutical Sciences, 2024, v. 19, n. 6, p. 754, doi. 10.4103/RPS.RPS_191_23
- By:
- Publication type:
- Article
Efficacy and safety of FLOT regimen vs DCF, FOLFOX, and ECF regimens as perioperative chemotherapy treatments for resectable gastric cancer patients; a report from the middle east.
- Published in:
- Research in Pharmaceutical Sciences, 2022, v. 17, n. 6, p. 621, doi. 10.4103/1735-5362.359430
- By:
- Publication type:
- Article
A 75-Year-Old Female Smoker with Advanced Small-Cell Lung Cancer and Eastern Cooperative Oncology Group Performance Status 2 who Responded to Combination Immunochemotherapy with Atezolizumab, Etoposide, and Carboplatin.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Delayed Diagnosis of Clostridium difficile Colitis in a 48-Year-Old Woman with a Homozygous Mutation of the UGT1A1 Gene While on Chemotherapy for Colorectal Carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
A Case of T-Cell Large Granular Lymphocytic Leukemia and Renal Immunoglobulin Heavy Chain Amyloidosis.
- Published in:
- American Journal of Case Reports, 2019, p. 43, doi. 10.12659/AJCR.912282
- By:
- Publication type:
- Article
ERCC1 and MGMT Methylation as a Predictive Marker of Relapse and FOLFOX Response in Colorectal Cancer Patients from South Tunisia.
- Published in:
- Genes, 2023, v. 14, n. 7, p. 1467, doi. 10.3390/genes14071467
- By:
- Publication type:
- Article
Assessment of the Cytotoxic Effect of a Series of 1,4-Dihydropyridine Derivatives Against Human Cancer Cells.
- Published in:
- Iranian Journal of Pharmaceutical Research, 2016, v. 15, n. 3, p. 413
- By:
- Publication type:
- Article
piscesCSM: prediction of anticancer synergistic drug combinations.
- Published in:
- Journal of Cheminformatics, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13321-024-00859-4
- By:
- Publication type:
- Article
Use of chemotherapy to treat hepatocellular carcinoma.
- Published in:
- BioScience Trends, 2022, v. 16, n. 1, p. 31, doi. 10.5582/bst.2022.01044
- By:
- Publication type:
- Article
Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer—Results of the prospective multicenter PERMAD trial.
- Published in:
- PLoS ONE, 2024, v. 19, n. 6, p. 1, doi. 10.1371/journal.pone.0304324
- By:
- Publication type:
- Article
Radial Data Visualization-Based Step-by-Step Eliminative Algorithm to Predict Colorectal Cancer Patients' Response to FOLFOX Therapy.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 22, p. 12149, doi. 10.3390/ijms252212149
- By:
- Publication type:
- Article
Cancer Treatment: New Drugs and Strategies.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 18, p. 9976, doi. 10.3390/ijms25189976
- By:
- Publication type:
- Article
Special Issue "Application Progress of Liposomes in Drug Development".
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 6, p. 3454, doi. 10.3390/ijms25063454
- By:
- Publication type:
- Article
In Vitro/In Vivo Translation of Synergistic Combination of MDM2 and MEK Inhibitors in Melanoma Using PBPK/PD Modelling: Part III.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 2239, doi. 10.3390/ijms24032239
- By:
- Publication type:
- Article
Tumor Targeting with Methotrexate-Conjugated Zwitterionic Near-Infrared Fluorophore for Precise Photothermal Therapy.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 14127, doi. 10.3390/ijms232214127
- By:
- Publication type:
- Article
Investigation of the Anticancer and Drug Combination Potential of Brominated Coelenteramines toward Breast and Prostate Cancer.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 13981, doi. 10.3390/ijms232213981
- By:
- Publication type:
- Article
In Vitro/In Vivo Translation of Synergistic Combination of MDM2 and MEK Inhibitors in Melanoma Using PBPK/PD Modelling: Part II.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 19, p. 11939, doi. 10.3390/ijms231911939
- By:
- Publication type:
- Article
Cardio-Oncology: Mechanisms, Drug Combinations, and Reverse Cardio-Oncology.
- Published in:
- 2022
- By:
- Publication type:
- Literature Review
NEXGB: A Network Embedding Framework for Anticancer Drug Combination Prediction.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 17, p. 9838, doi. 10.3390/ijms23179838
- By:
- Publication type:
- Article
Melanoma Cellular Plasticity.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 12, p. 6401, doi. 10.3390/ijms23126401
- By:
- Publication type:
- Article
The Role of Low-Energy Electron Interactions in cis-Pt(CO) 2 Br 2 Fragmentation.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 16, p. 8984, doi. 10.3390/ijms22168984
- By:
- Publication type:
- Article
In Vitro Effects of Selective COX and LOX Inhibitors and Their Combinations with Antineoplastic Drugs in the Mouse Melanoma Cell Line B16F10.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 12, p. 6498, doi. 10.3390/ijms22126498
- By:
- Publication type:
- Article
New Targeted Agents in Acute Myeloid Leukemia: New Hope on the Rise.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 8, p. 1983, doi. 10.3390/ijms20081983
- By:
- Publication type:
- Article
FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: a retrospective observational study.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10654-3
- By:
- Publication type:
- Article
Discovery of Drug Synergies in Gastric Cancer Cells Predicted by Logical Modeling.
- Published in:
- PLoS Computational Biology, 2015, v. 11, n. 8, p. 1, doi. 10.1371/journal.pcbi.1004426
- By:
- Publication type:
- Article
Atypical MYC rearrangement pattern of 3′ deletion and 5′ amplification along with independent IGH rearrangement: A case study.
- Published in:
- Indian Journal of Cancer, 2022, v. 59, n. 4, p. 548, doi. 10.4103/ijc.IJC_1292_20
- By:
- Publication type:
- Article
Thiostrepton induces spindle abnormalities and enhances Taxol cytotoxicity in MDA-MB-231 cells.
- Published in:
- Molecular Biology Reports, 2024, v. 51, n. 1, p. 1, doi. 10.1007/s11033-024-09863-1
- By:
- Publication type:
- Article
Advances in Engineered Biomaterials Targeting Angiogenesis and Cell Proliferation for Cancer Therapy.
- Published in:
- Chemical Record, 2022, v. 22, n. 12, p. 1, doi. 10.1002/tcr.202200152
- By:
- Publication type:
- Article
A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1547, doi. 10.1007/s00262-019-02383-z
- By:
- Publication type:
- Article
A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1505, doi. 10.1007/s00262-018-2198-9
- By:
- Publication type:
- Article
Effect of Xymedon and Mexidol in Combination with Antineoplastic Drugs on Spermatogenesis Indicators and Functional State of Spermatozoa in Rats with Walker-256 Carcinoma.
- Published in:
- Bulletin of Experimental Biology & Medicine, 2021, v. 171, n. 4, p. 435, doi. 10.1007/s10517-021-05244-x
- By:
- Publication type:
- Article
Combination of MexAB-OprM overexpression and mutations in efflux regulators, PBPs and chaperone proteins is responsible for ceftazidime/avibactam resistance in Pseudomonas aeruginosa clinical isolates from US hospitals.
- Published in:
- 2019
- By:
- Publication type:
- journal article